P53 Gene Mutation and mdm2 Gene Amplification Are Uncommon in Medulloblastoma

Cancer Research

Volumn 54, Issue 21, 1994, Pages 5649-5651

  Adesina, Adekunle M ^a   Nalbantoglu, Josephine ^a   Cavenee, Webster K ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 17; CONFORMATIONAL TRANSITION; DNA CONFORMATION; DNA POLYMORPHISM; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE MUTATION; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BASE SEQUENCE; CEREBELLAR NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 17; GENE AMPLIFICATION; GENES, P53; HUMANS; MEDULLOBLASTOMA; MOLECULAR SEQUENCE DATA; POINT MUTATION;

EID: 0028172248     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Russell, D.S. and Rubeinstein, L.J. Pathology of Tumors of the Central Nervous System, Ed. 5, pp. 251-270, 1989.
2. Bigner, S.H. Mark, J. Friedman, H.S. Biegel, J.A. and Bigner, D.D. Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet. Cytogenet. 30: 91-101, 1988.
3. Cogen, P.H. Daneshvar, L. Metzger, A.K. and Edwards, M.S.B. Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics, 8: 279-285, 1990.
4. Thomas, G.A. and Raffel, C. Loss of heterozygosity on 6q, 16q and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res. 51: 639-643, 1991.
5. James, C.D. Ju, He, Carlbom, E. Mikkelsen, T. Ridderheim, P. Cavenee, W.K. and Collins, V.P. Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chromosomes Cancer, 2: 94-102, 1990.
6. Wasson, J.C. Saylors, R.L. III, Zelter, P. Friedman, H.S. Bigner, S.H. Burger, P.G. Bigner, D.D. Look, A.T. Douglas, E.C. and Brodeur G.M. Oncogene amplification in pediatric brain tumors. Cancer Res. 50: 2987-2990, 1990.
7. Cogen, P.H. Daneshvar, L. Metzger, A.K. Duyk, G. Edwards, M.S.B. and Sheffields, V.C. Involvement of multiple 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Genet. 50: 584-589, 1992.
8. Biegel, J.A. Burk, C.D. Barr, F.G. and Emanuel, B.S. Evidence for a 17p tumor related locus distinct from p. 3 in pediatric primitive neuroectodermal tumors. Cancer Res. 52: 3391-3395, 1992.
9. Levine, A. Momand, J. and Finlay, C.A. The p. 3 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
10. Holstein, M. Sidransky, D. Vogelstein, B. and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
11. Mulligan, L.M. Matalashewski, G.J. Scrable, H.J. and Cavenee, W.K. Mechanisms of p. 3 loss in human sarcomas Proc. Natl. Acad. Sci. USA, 87: 5863-5867, 1990.
12. Sidransky, D. Mikkelsen, T. Schehheimer, K. Rosenblum, M. Cavenee, W. and Vogelstein, B. Clonal expansion of p. 3 mutant cells is associated with brain tumor progression. Nature (Lond.), 355: 846-847, 1992.
13. Kern, S.E. Kinzler, K.W. Bruskin, A. Jarosz, D. Friedman, P. Prives, C. and Vogelstein, B. Identification of p. 3 as a sequence specific DNA binding protein. Science (Washington DC), 252: 1708-1711, 1991.
14. Mercer, W.E. Shields, M.T. Amin, M. Sauve, G.J. Appella, E. Romano, J.W. and Ullrich, S.J. Negative regulation in a glioblastoma tumor cell line that conditionally expresses human wild type p. 3. Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
15. Sherley, J. Guanine nucleotide biosynthesis is regulated by the cellular p. 3 concentration J. Biol. Chem. 266: 24815-24828, 1991.
16. El-Deiry, W.S. Tokino, T. Velculescu, V.E. Levy, D.B. Parsons, R. Trent, J.M. Lin, D. Mercer, W.E. Kinzler, K.W. and Vogelstein, B. WAF1, a potential mediator of p. 3 tumor suppression. Cell, 75: 817-825, 1993.
17. Raycroft, L. Schmidt, J.R. Yoas, K. Hao, M. and Lozano, G. Analysis of p. 3 mutants for transcriptional activity. Mol. Cell. Biol. 11: 6067-6074, 1991.
18. Yin, Y. Tainsky, M.A. Bischoff, F.Z. Strong, L.C. and Wahl, G.M. Wild type p. 3 restores cell cycle control and inhibits gene amplification in cells with mutant p. 3 alleles. Cell, 70: 937-948, 1992.
19. Barak, Y. Juven, T. Haffner, R. and Oren, M. mdm2 expression is induced by wild type p. 3 activity. EMBO J. 12: 461-468, 1993.
20. Oliner, J.D. Kinzler, K.W. Meltzer, P.S. George, D.L. and Vogelstein, B. Amplification of a gene encoding a p. 3 associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
21. Ladanyi, M. Cha, C. Lewis, R. Jhanwar, S.C. Huvos, A.G. and Healey, J.H. mdm2 gene amplification in metastatic osteosarcoma. Cancer Res. 53: 16-18, 1993.
22. Khatib, Z.A. Matsushime, H. Valentine, M. Shapiro, D.N. Sherr, C.J. and Look, A.T. Coamplification of the cdk4 gene with mdm2 and gli in human sarcomas. Cancer Res. 53: 5535-5541, 1993.
23. Felix, C.A. Chavez, K.C. Mitsudomi, T. Nau, M.M. Tsokos, M. Crouch, G.D. Nisen, P.D. Winick, NJ. and Helman, L.J. Frequency and diversity of p. 3 mutations in childhood rhabdomyosarcoma. Cancer Res. 52: 2243-2247, 1992.
24. Ueda, Y. Dockhorn-Dworniczak, B. Blasius, S. Mellin, W. Wuisman, P. Booker, W. and Roesner, A. Analysis of mutant p. 3 protein in osteosarcoma and other malignant and benign lesions of bone. J. Cancer Res. Clin. Oncol. 119: 172-178, 1993.
25. Waber, P.G. Chen, J. and Nissen, P.D. Infrequency of mdm2 gene amplification in pediatric solid tumors and lack of association with p. 3 mutations in adult squamous cell carcinomas. Cancer Res. 53: 6028-6030, 1993.
26. Oghaki, H. Eibi, R.H. Wiestler, O.D. Vasargil, M.G. Newcomb, E.W. and Kleihues, P. p. 3 mutations in nonastrocytic human brain tumors. Cancer Res. 51: 6202-6205, 1991.
27. Saylors, R.L. III, Sidransky, D. Friedman, H.S. Bigner, S.H. Bigner, D.D. Vogelstein, B. and Brodeur, G.M. Infrequent p. 3 gene mutations in medulloblatomas. Cancer Res. 51: 4721-4723, 1991.
28. Orita, M. Suzuki, Y. Sekiya, T. and Hayashi, K. Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
29. Sambrook, J. Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
30. Feinberg, A.P. and Vogelstein, B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137: 266-267, 1984.
31. Takahashi, T. Nau, M.M. Chiba, I. Birrer, M.J. Rosenberg, R.K. Vinocour, M. Levitt, M. Pass, H. Gazdar, A.F. and Minna, J.D. p. 3: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
32. Rideout, W.M. Coetzee, G.A. Olumi, A.F. and Jones, P.A. 5-methyl-cytosine as an endogenous mutagen in human LDL receptor and p. 3 genes. Science (Washington DC), 249: 1288-1290, 1990.
33. Pusieux, A. Lim, S. Groopman, J. and Ozturk, M. Selective targeting of p. 3 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 51: 6185-6189, 1991.